Document Detail


Combination thrombolytic and anticoagulant therapy for bilateral renal vein thrombosis in a premature infant.
MedLine Citation:
PMID:  11552182     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We report a premature infant with bilateral renal vein thrombosis and renal failure at 1 month of age who underwent treatment with recombinant tissue plasminogen activator and heparin sulfate. Combination thrombolytic and anticoagulation therapy was complicated by an intraventricular and intraparenchymal cerebral hemorrhage without resolution of the renal vein thrombosis. With increasing reports of successful use of this therapy for venous thrombosis, we suggest caution and continued study of its use in the premature infant and newborn.
Authors:
N Weinschenk; M Pelidis; J Fiascone
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  American journal of perinatology     Volume:  18     ISSN:  0735-1631     ISO Abbreviation:  Am J Perinatol     Publication Date:  2001 Aug 
Date Detail:
Created Date:  2001-09-11     Completed Date:  2001-10-25     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8405212     Medline TA:  Am J Perinatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  293-7     Citation Subset:  IM    
Affiliation:
Division of Newborn Medicine, Department of Pediatrics, Floating Hospital for Children, Tufts University School of Medicine, Boston, Massachusetts, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / therapeutic use*
Fibrinolytic Agents / therapeutic use
Heparin / therapeutic use
Humans
Infant, Newborn
Infant, Premature, Diseases / drug therapy*
Recombinant Proteins / therapeutic use
Renal Artery Obstruction / drug therapy*
Thrombolytic Therapy*
Thrombosis / drug therapy*
Tissue Plasminogen Activator / therapeutic use*
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Fibrinolytic Agents; 0/Recombinant Proteins; 9005-49-6/Heparin; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Unusual presentation of neonatal Behcets disease.
Next Document:  Discharge disposition from acute care after traumatic brain injury: the effect of insurance type.